Recurrent somatic loss ofTNFRSF14in classical Hodgkin lymphoma
نویسندگان
چکیده
منابع مشابه
Hodgkin Lymphoma and Anaplastic Variants of Non-Hodgkin Lymphoma
Background and Objectives: Classic Hodgkin lymphoma (CHL), anaplastic large cell lymphoma (ALCL) and some cases of diffuse large B cell lymphoma (DLBCL) have overlapping morphologic features. Since they all represent distinct clinico-pathologic entities, we explored the differential diagnostic impact of immunophenotyping to discriminate between them. Materials and Methods:...
متن کاملTargeted therapy in relapsed classical hodgkin lymphoma.
Although frontline treatment of advanced Hodgkin lymphoma (HL) produces high cure rates, disease either will not respond to or will relapse after initial therapy in approximately a quarter of patients. Many patients with disease relapse can be successfully salvaged with second-line chemotherapy followed by autologous stem cell transplantation (ASCT). Patients whose disease relapses after ASCT a...
متن کاملEpidemiology and prognosis in classical Hodgkin lymphoma
Hollander, P. 2018. Epidemiology and prognosis in classical Hodgkin lymphoma. Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1411. 70 pp. Uppsala: Acta Universitatis Upsaliensis. ISBN 978-91-513-0189-1. Classical Hodgkin lymphoma (HL) is a B cell derived neoplasm with an overall good prognosis. Its etiology and pathogenesis are largely unknown. The tumor m...
متن کاملMonoclonal antibody therapy for classical Hodgkin lymphoma
8531 (2009). Monoclonal antibody therapy for classical Hodgkin lymphoma Review: Clinical Trial Outcomes future science groupClin. Invest. (2013) 3(9)90932 Thertulien R, Frankel AE, Evens AM et al. APhase I, open-label, dose-escalation,multidose study of MDX-1401 (defucosylatedhuman antiCD30 monoclonal antibody) inpatients with CD30-positive refractory/relapsed Ho...
متن کاملLYMPHOID NEOPLASIA JAK2 rearrangements, including the novel SEC31A-JAK2 fusion, are recurrent in classical Hodgkin lymphoma
1Center for Human Genetics, Katholieke Universiteit Leuven, Leuven, Belgium; 2VIB Department of Molecular and Developmental Genetics, VIB, Leuven, Belgium; 3Morphology and Molecular Pathology Section, University Hospitals Leuven, Leuven, Belgium; 4Laboratory of Hematology, AZ St Jan AV, Brugge, Belgium; 5Department of Pathology, AZ St Jan AV, Brugge, Belgium; and 6Department of Hematology, Univ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Genes, Chromosomes and Cancer
سال: 2015
ISSN: 1045-2257
DOI: 10.1002/gcc.22331